Vos Ellen O'Connor Insider Trading Activity

Average Profitability
37.01%
Insider Buys Quantity
29
Insider Buys Sum
$267,330.50
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Vos Ellen O'Connor

Biography of Vos Ellen O'Connor

No biography is available at this moment.

2022-08-16PurchaseOptimizeRx Corporation
OPRX
500
0.0028%
$15.91$7,955-4.87%
2021-10-28PurchaseModular Medical, Inc.
MODD
Chief Executive Officer
55,555
0.2914%
$2.70$149,999
2020-03-31PurchaseOptimizeRx Corporation
OPRX
director
2,000
0.0132%
$8.75$17,500+121.41%
2019-11-13PurchaseOptimizeRx Corporation
OPRX
director
1,200
0.0082%
$9.62$11,544+15.78%
2018-10-08PurchaseOptimizeRx Corporation
OPRX
director
4,168
–
$0$0-14.13%
2018-06-29PurchaseOptimizeRx Corporation
OPRX
director
2,084
–
$0$0+26.78%
2018-06-25PurchaseOptimizeRx Corporation
OPRX
director
2,700
0.0252%
$10.52$28,394+27.41%
2018-06-22PurchaseOptimizeRx Corporation
OPRX
director
900
0.0082%
$10.34$9,309+25.34%
2017-05-03PurchaseOptimizeRx Corporation
OPRX
director
2,000
0.0068%
$0.75$1,500+77.33%
2017-04-12PurchaseOptimizeRx Corporation
OPRX
director
4,000
0.0135%
$0.74$2,960+72.97%
2017-03-24PurchaseOptimizeRx Corporation
OPRX
director
2,000
0.0065%
$0.78$1,560+54.32%
2017-03-23PurchaseOptimizeRx Corporation
OPRX
director
2,000
0.0065%
$0.78$1,560+54.32%
2017-03-22PurchaseOptimizeRx Corporation
OPRX
director
4,000
0.0129%
$0.78$3,100+54.32%
2017-03-21PurchaseOptimizeRx Corporation
OPRX
director
2,000
0.007%
$0.78$1,550+66.67%
2017-03-20PurchaseOptimizeRx Corporation
OPRX
director
2,000
0.0065%
$0.78$1,560+54.32%
2017-03-17PurchaseOptimizeRx Corporation
OPRX
director
2,000
0.0066%
$0.78$1,560+56.25%
2017-03-16PurchaseOptimizeRx Corporation
OPRX
director
4,000
0.013%
$0.78$3,120+54.32%
2017-03-14PurchaseOptimizeRx Corporation
OPRX
director
2,000
0.0067%
$0.80$1,600+55%
2017-03-13PurchaseOptimizeRx Corporation
OPRX
director
4,000
0.013%
$0.78$3,100+55%
2017-03-10PurchaseOptimizeRx Corporation
OPRX
director
2,000
0.0071%
$0.78$1,560+67.57%
Total: 29
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.